Skip to main content

Table 2 Sensitivity analysis for cost-effectiveness analysis of the implementation of colorectal cancer screening programme in the Basque population

From: Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

  

Screened population costs

Incremental costs

QALYs gained

ICER

Cost per invitation

Adenoma prevalence

Treatment cost

Total costs

Treatment cost

Total costs

  

€6.06 per invitation

Base case

 Men

1199.9

1317.0

−179.1

−81.7

37,132.5

Dominant

 Women

664.2

740.2

−77.1

−11.4

19,532.3

Dominant

 Total

1864.1

2057.2

−256.3

−93.1

56,664.8

Dominant

Prevalence Bibliography

 Men

1227.5

1318.9

−168.6

−97.2

36,616.9

Dominant

 Women

661.0

726.9

−77.6

−21.8

20,438.5

Dominant

 Total

1888.5

2045.7

− 246.2

−119.0

57,055.4

Dominant

€15.00 per invitation

Base case - Total

1864.1

2103.2

−256.3

−47.1

56,664.8

Dominant

€20.00 per invitation

Base case - Total

1864.1

2128.9

−256.3

−21.4

56,664.8

Dominant

€25.00 per invitation

Base case - Total

1864.1

2154.6

−256.3

4.2

56,664.8

74.1

€30.00 per invitation

Base case - Total

1864.1

2180.3

−256.3

30.0

56,664.8

529.4

€40.00 per invitation

Base case - Total

1864.1

2231.8

−256.3

81.5

56,664.8

1438.3

€50.00 per invitation

Base case - Total

1864.1

2283.2

−256.3

132.9

56,664.8

2345.4

  1. ICER incremental cost effectiveness ratio